Possible indirect detection of rHuEPO administration in human urine by high-performance liquid chromatography tandem mass spectrometry

European Journal of Mass Spectrometry

Volumn 14, Issue 3, 2008, Pages 201-209

  Appolonova, Svetlana A ^a   Dikunets, Marina A ^a   Rodchenkov, Grigory M ^a  

^a Moscow Antidoping Centre   (Russian Federation)

Author keywords

ADMA; Arginine; Citrulline; Collision induced dissociation; Doping; Erythropoietin; Fragmentation; Indirect method; Liquid chromatography; Mass spectrometry; SDMA; Sport

Indexed keywords

AMIDASE; ARGININE; BIOLOGICAL MARKER; CITRULLINE; DIMETHYLARGININASE; DIMETHYLARGININE; DRUG DERIVATIVE; NITRIC OXIDE SYNTHASE; RECOMBINANT ERYTHROPOIETIN;

ADULT; ARTICLE; DOPING; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; METHODOLOGY; PREDICTION AND FORECASTING; REFERENCE VALUE; SUBSTANCE ABUSE; TANDEM MASS SPECTROMETRY; URINE;

ADULT; AMIDOHYDROLASES; ARGININE; BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CITRULLINE; DOPING IN SPORTS; ERYTHROPOIETIN, RECOMBINANT; HUMANS; INJECTIONS, INTRAVENOUS; MALE; NITRIC OXIDE SYNTHASE; PREDICTIVE VALUE OF TESTS; REFERENCE VALUES; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SUBSTANCE ABUSE DETECTION; TANDEM MASS SPECTROMETRY;

EID: 50649091590     PISSN: 14690667     EISSN: None     Source Type: Journal    
DOI: 10.1255/ejms.922     Document Type: Article

References (27)

1. F. Lasne, L. Martin, N. Crepin and J. Ceaurriz, "Detection of isoelectric profiles of erythropoietin in urine: differentiation of natural and administered recombinant hormones", Anal. Biochem. 311, 119 (2002). doi: 10.1016/ S0003-2697(02)00407-4
2. D.H. Catlin, A. Breidbach, S. Elliott and J. Glaspy, "Comparison of the Isoelectric Focusing Patterns of Darbepoetin Alfa, Recombinant Human Erythropoietin and Endogenous Erythropoietin from Human Urine", Clin. Chem. 48, 2057 (2002).
3. R. Parisotto, M. Wu, M.J. Ashenden, K.R. Emslie, C.J. Gore, C. Howe, R. Kazauskas, K. Sharpe, G.J. Trout, M. Xie and A.G. Hahn, "Detection of recombinant human erythropoietin abuse in athletes utilizing markers of altered erythropoiesis", Haematologica 86, 128 (2001).
4. F.H.Jr. Wians, J.E. Urban, S.H. Kroft and J.H. Keffer, "Soluble transferrin receptor (sTfR) concentration quantided using two sTfR kits: analytical and clinical performance characteristics", Clin. Chim. Acta. 303, 75 (2001). doi: 10.1016/S0009-8981(00)00376-4
5. N.D. Vaziri, X.J. Zhou, J. Smith, F. Oveisi, K. Baldwin and R.E. Purdy, "In vivo and in vitro pressor effects of erythropoietin in rats", Am. J. Physiot. 269, 838 (1995).
6. X.Q. Wang and N.D. Vaziri, "Erythropoietin depresses nitric oxide synthase expression by human endothelial cells", Hypertension 33, 894 (1999).
7. H. Miyazaki, H. Matsuoka, J.P. Cooke, M. Usui, S. Ueda, S. Okuda, T. Imaizumi, "Endogenous nitric oxide synthase inhibitor a novel marker of atherosclerosis", Circulation. 99, 1141 (1999).
8. C. Zoccali, S.M. Bode-Böger, F. Mallamaci, F. Benedetto, G. Tripepi, L. Malatino, A. Cataliotti, I. Bellanuova, I. Fermo, J. Frolich and R.H. Böger, "Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: A prospective study", Lancet 358, 2113 (2001). doi: 10.1016/S0140-6736(01)07217-8
9. J.P. Cooke, "Asymmetrical dimethylarginine. The Uber marker?", Circulation 109, 1813 (2004). doi: 10.1161/01. CIR.0000126823.07732.D5
10. P. Vallance and J. Leiper, "Cardiovascular biology of the asymmetric dimethylarginine: Dimethylarginine dimethylaminohydrolase pathway", Arterioscler. Thromb. Vasc. Biol. 24, 1023 (2004). doi: 10.1161/01. ATV.0000128897.54893.26
11. F. Scalera, J.T. Kielstein, J. Martens-Lobenhoffer, S.C. Postel, M. Täger and S.M. Bode-Böger, "Erythropoietin increases asymmetric dimethylarginine in endothelial cells: role of dimethylarginine dimethylaminohydrolase", J. Am. Soc. Nephrol. 16, 892 (2005). doi: 10.1681/ ASN.2004090735
12. J. Martens-Lobenhoffer and S.M. Bode-Böger, "Fast and efficient determination of arginine, aymmetric dimethylarginine and asymmetric dimethylarginine in biological fluids by hydrophilic-interaction liquid chromatography-electrospray tandem mass spectrometry", Clin. Chem. 52, 488 (2006). doi: 10.1373/clinchem.2005.060152
13. K. Chobanyan, T. Thum, M.T. Suchy, B Zhu, A. Mitschke, F.M. Gutzki, B. Beckmann, D.O. Stichtenoth and D. Tsikas, "GC-MS assay for hepatic DDAH activity in diabetic and non-diabetic rats by measuring dimethylamine (DMA) formed from asymmetric dimethylarginine (ADMA): Evaluation of the importance of S-nitrosothiots as inhibitors of DDAH activity in vitro and in vivo in humans", J. Chromatogr. B Anatyt. Technol. Biomed. Life Sci. 858, 32 (2007). doi: 10.1016/j. jchromb.2007.08.002
14. D. Tsikas, T. Thum, T. Becker, V.V. Pham, K. Chobanyan, A. Mitschke, B. Beckmann, F.M. Gutzki, J. Bauersachs and D.O. Stichtenoth, "Accurate quantification of dimethylamine (DMA) in human urine by gas chromatography-mass spectrometry as pentafluorobenzamide derivative: evaluation of the relationship between DMA and its precursor asymmetric dimethylarginine (ADMA) in health and disease", J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 851, 229 (2007). doi: 10.1016/j. jchromb.2006.09.015
15. K. Chobanyan, A. Mitschke, F.M. Gutzki, D.O. Stichtenoth and D. Tsikas, "Accurate quantification of dimethylamine (DMA) in human plasma and serum by GC-MS and GC-tandem MS as pentafluorobenzamide derivative in the positive-ion chemical ionization mode", J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 851, 240 (2007). doi: 10.1016/j.jchromb.2007.03.006
16. A. Meinitzer, M. Puchinger, B.M. Winklhofer-Roob, E. Rock, J. Ribalta, J.M. Roob, I. Sundl, G. Halwachs-Baumann and W. März, "Reference values for plasma concentrations of asymmetrical dimethylarginine (ADMA) and other arginine metabolites in men after validation of a chromatographic method", Clin. Chim. Acta. 384, 141 (2007). doi: 10.1016/j.cca.2007.07.006
17. B. Beckmann, F.M. Gutzki and D. Tsikas, "Sensitivity enhancement of a GC-MS/MS method for asymmetric dimethylarginine (ADMA) by plasma ultrafiltrate reduction", Anal. Biochem. 372, 264 (2008). doi: 10.1016/j. ab.2007.09.010
18. T. Teerlink, "HPLC analysis of ADMA and other methylated L-arginine analogs in biological fluids", J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 851, 21 (2007). doi: 10.1016/j.jchromb.2006.07.024
19. F. Schulze, E. Schwedhelm, R. Maas and R.H. Böger, "Comparison of HPLC method and commercial ELISA assay for asymmetric dimethylarginine (ADMA) determination in human serum", J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 831, 333 (2006). doi: 10.1016/j. jchromb.2005.11.015
20. S. Nonaka, M. Tsunoda, K. Imai, T. Funatsu. "High-performance liquid chromatographic assay of N(G)-monomethyl-L-arginine, N(G),N(G)-dimethyl-L- arginine and N(G),N(G)'-dimethyl-L-arginine using 4-fluoro-7-nitro-2, 1,3-benzoxadiazole as a fluorescent reagent", J. Chromatogr. A. 1066, 41 (2005). doi: 10.1016/j. chroma.2005.01.052
21. M.J. Bishop, B. Crow, D. Norton, E. Paliakov, J. George and J.A. Bralley, "Direct analysis of un-derivatized asymmetric dimethylarginine (ADMA) and L-arginine from plasma using mixed-mode ion-exchange liquid chromatography- tandem mass spectrometry", J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 859, 164 (2007). doi: 10.1016/j.jchromb.2007.09.024
22. E. Schwedhelm, R. Maas, J. Tan-Andresen, F. Schulze, U. Riederer and R.H. Böger, "High-throughput liquid chromatographic-tandem mass spectrometric determination of arginine and dimethylated arginine derivatives in human and mouse plasma", J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 851, 211 (2007). doi: 10.1016/j. jchromb.2006.11.052
23. J. Martens-Lobenhoffer and S.M. Bode-Böger, "Chromatographic- mass spectrometric methods for the quantification of L-arginine and its methylated metabolites in biological fluids", J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 851, 30 (2007). doi: 10.1016/j. jchromb.2006.07.038
24. J. Rappsilber, W.J. Friesen, S. Paushkin, G. Dreyfuss and M. Mann, "Detection of arginine dimethylated peptides by parallel precursor ion scanning mass spectrometry in positive ion mode", Anal. Chem. 75, 3107 (2003). doi: 10.1021/ac026283q
25. C.J. Brame, M.F. Moran and L.D. McBroom-Cerajewski, "A mass spectrometry based method for distinguishing between symmetrically and asymmetrically dimethylated arginine residues", Rapid Commun. Mass Spectrom. 18, 877 (2004). doi: 10.1002/rcm.1421
26. P.M. Gehring, P.E. Hunziker, S. Zahariev and S. Pongor, "Fragmentation pathways of NG-methylated and unmodified arginine residues in peptides studied by ESi-MS/MS and MALDI-MS", J. Am. Soc. Mass Spectrom. 15, 142 (2004). doi: 10.1016/j. jasms.2003.10.002
27. w-arginine dimethylation modulates the interaction between a Gly/Arg-rich peptide from human nucleolin and nucleic acids", Nucleic Acids Res. 29, 3377 (2001). doi: 10.1093/nar/29.16.3377